24 May 2013
Keywords: chiron, drops, aerogen, favor, inhale, pulmonary, antibiotic
Article | 06 December 2001
Chiron has discontinued its collaboration with US developer of inhaleddrug formulations, Aerogen, in favor of a new agreement with rival ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 October 2001
11 February 2002
23 May 2013
© 2013 thepharmaletter.com